Sunshine Biopharma Inc. is a Colorado corporation with head offices in Montreal, Canada. The Company is fully reporting in the U.S. (www.SEC.gov) and Canada (www.SEDAR.com). Sunshine Biopharma’s Common Shares are traded on the OTC market under the ticker symbol SBFM.
Sunshine Biopharma conducts its operations through three (3) wholly owned subsidiaries:
- Atlas Pharma Inc. (“Atlas”), a Canadian company dedicated to chemical analysis of pharmaceutical and other industrial samples. Atlas’ operations are authorized by a Drug Establishment License issued by Health Canada. Atlas is also registered with the FDA. Learn more...
- Sunshine Biopharma Canada Inc. (“Sunshine Canada”), a Canadian company formed in 2014 for the purposes of offering generic prescription pharmaceuticals in Canada and elsewhere around the world. Sunshine Canada has signed licensing agreements for four (4) generic prescription drugs for the treatment of breast cancer, prostate cancer and BPH (Benign Prostatic Hyperplasia). Learn more...
- NOX Pharmaceuticals, Inc. (“NOX”) is a Colorado corporation dedicated to the research, development and commercialization of proprietary drugs including Adva27a, the Company’s flagship proprietary drug for the treatment of cancer. Adva-27a, is a small molecule that has proven effective against different types of multidrug resistant cancer including breast cancer cells (MCF-7/MDR), small-cell lung cancer cells (H69AR), uterine carcinoma cells (MES-SA/Dx5) and pancreatic cancer cells (Panc-1). Learn more...
September 14, 2018
Sunshine Biopharma Announces $10 Million Equity Financing
June 18, 2018
Sunshine Biopharma Launches Microbiology Testing Service
January 4, 2018
Sunshine Biopharma Completes the Acquisition of Atlas Pharma